Abstract
Understanding and forecasting infectious disease spread is pivotal for effective public health management. Traditional dynamic disease modeling is an essential tool for characterization and prediction, but often requires extensive expertise and specialized software, which may not be readily available in low-resource environments. To address these challenges, we introduce an AI-powered modeling assistant that utilizes advanced capabilities from OpenAI’s latest models and functionality. This tool enhances the accessibility and usability of infectious disease models and simulation frameworks by allowing users to generate or modify model configurations through intuitive natural language inputs or by importing explicit model descriptions. Our prototype integrates with an established open-source disease simulation framework called the Compartmental Modeling Software (CMS) to provide a seamless modeling experience from setup to analysis. The AI assistant efficiently interprets disease model parameters, constructs accurate model files, executes simulations in a controlled environment, and assists in result interpretation using advanced analytics tools. It encapsulates expert knowledge and adheres to best practices to support users ranging from novices to expert modelers. Furthermore, we discuss the limitations of this AI assistant, particularly its performance in complex scenarios where it might generate inaccurate specifications. By enhancing the ease of disease modeling and supporting ongoing capacity-building initiatives, we believe that AI assistants like this one could significantly contribute to global health efforts by empowering researchers, especially in regions with limited resources, to develop and refine their disease models independently. This innovative approach has the potential to democratize disease modeling in global health, offering a scalable solution that adapts to diverse needs across a wide-range of geographies, languages, and populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
There was not primary data produced by this study.
